The Effect of Teriparatide Treatment on Spinal Deformity Index in Severe Osteoporosis

The Effect of Teriparatide Treatment on Spinal Deformity Index in Severe Osteoporosis

Objective:This study’s purpose was to evaluate the efficacy of teriparatide (TPTD) therapy on back pain, quality of life, and spinal deformity index (SDI) in the presence of established postmenopausal osteoporosis.Materials and Methods:The mean ages of 21 patients with established osteoporosis were...

Full description

Bibliographic Details
Main Authors:	Fatma Gül Ülkü Demir, Mustafa Çalış, Havva Talay Çalış, Kürşad Ünlühızarcı, Esra Sonbahar Bolat, Selçuk Mıstık
Format:	Article
Language:	English
Published:	Galenos Yayinevi 2019-04-01
Series:	Türk Osteoporoz Dergisi
Subjects:	Teriparatide quality of life spinal deformity index established osteoporosis
Online Access:	http://www.turkosteoporozdergisi.org/archives/archive-detail/article-preview/the-effect-of-teriparatide-treatment-on-spinal-def/27377

Similar Items

Teriparatide - Indications beyond osteoporosis
by: Marilyn Lee Cheng, et al.
Published: (2012-01-01)

Teriparatide as option for severe osteoporosis
by: Mara CARSOTE, et al.
Published: (2016-12-01)

Contributors to Secondary Osteoporosis in Patients Referred for Treatment with Teriparatide
by: İnan Anaforoğlu, et al.
Published: (2013-12-01)

Impressive results of teriparatide treatment of postgastrectomy osteoporosis
by: Tatjana Bačun, et al.
Published: (2011-08-01)

Review of Current Real-World Experience with Teriparatide as Treatment of Osteoporosis in Different Patient Groups
by: Barbara Hauser, et al.
Published: (2021-04-01)

Teriparatide and denosumab treatment for pregnancy and lactation-associated osteoporosis with multiple vertebral fractures: A case study
by: Akifumi Ijuin, et al.
Published: (2017-12-01)

The Russian Council of Experts for Use of the Innovative Anabolic Agent Forsteo®(Teriparatide) in the Treatment of Severe Osteoporosis
by: Olga Mikhailovna Lesnyak
Published: (2013-10-01)

Teriparatide (recombinant human parathyroid hormone 1-34) in postmenopausal women with osteoporosis: systematic review
by: Virgínia Fernandes Moça Trevisani, et al.

Outcomes of Treatment in Patients with Severe Postmenopausal Osteoporosis: The Effects of Teriparatide Treatment on Bone Mineral Density, Back Pain and Biochemical Parameters
by: Tuba Nazlıgül, et al.
Published: (2020-04-01)

Effects of teriparatide in Chinese and Caucasian women with osteoporosis: bridging study on efficacy
by: Xie Z, et al.
Published: (2019-05-01)

Normocalcemic primary hyperparathyroidism in a patient with severe osteoporosis receiving teriparatide
by: Vishal Gupta
Published: (2013-01-01)

Response to teriparatide in Chinese patients with established osteoporosis: osteocalcin and lumbar spine bone-mineral density changes from teriparatide Phase III study
by: Lu C, et al.
Published: (2017-10-01)

Teriparatide Treatment in Patients with Severe Osteoporosis: Effects on Bone Mineral Density, Biochemical Parameters, Back Pain and Quality of Life
by: Alev Çevikol, et al.
Published: (2014-08-01)

An observational study to assess back pain in patients with severe osteoporosis treated with teriparatide versus antiresorptives: An Indian subpopulation analysis
by: Harvinder Chhabra, et al.
Published: (2015-01-01)

Use of teriparatide in treatment of severe osteoporosis in geriatric practice: a clinical case review
by: Ekaterina N. Dudinskaya, et al.
Published: (2020-03-01)

More than 6 Months of Teriparatide Treatment Was More Effective for Bone Union than Shorter Treatment Following Lumbar Posterolateral Fusion Surgery
by: Seiji Ohtori, et al.
Published: (2015-08-01)

The cost effectiveness of teriparatide as a first-line treatment for glucocorticoid-induced and postmenopausal osteoporosis patients in Sweden
by: Murphy Daniel R, et al.
Published: (2012-10-01)

Does Discontinuing Teriparatide Treatment and Replacing It with Bisphosphonate Maintain the Volume of the Bone Fusion Mass after Lumbar Posterolateral Fusion in Women with Postmenopausal Osteoporosis?
by: Seiji Ohtori, et al.
Published: (2017-04-01)

Effects of denosumab versus teriparatide in glucocorticoid-induced osteoporosis patients with prior bisphosphonate treatment
by: Yasuaki Hirooka, et al.
Published: (2020-12-01)

Abaloparatide exhibits greater osteoanabolic response and higher cAMP stimulation and β‐arrestin recruitment than teriparatide
by: Karim Sahbani, et al.
Published: (2019-10-01)

Hypercalcemic encephalopathy due to milk alkali syndrome and injection teriparatide
by: Sandeep Kharb, et al.
Published: (2012-01-01)

A Rare Cause of Back Pain after Pregnancy: Postpartum Osteoporosis and Treatment Approach
by: Muzaffer İlhan, et al.
Published: (2016-12-01)

Four-Year Teriparatide Followed by Denosumab vs. Continuous Denosumab in Glucocorticoid-Induced Osteoporosis Patients With Prior Bisphosphonate Treatment
by: Yasuaki Hirooka, et al.
Published: (2021-09-01)

The Effect of Daily Teriparatide versus One-Time Annually Zoledronic Acid Administration After Transforaminal Lumbar Interbody Fusion in Osteoporotic Patients
by: Wang Z, et al.
Published: (2021-10-01)

Teriparatide Treatment Following Osteoporotic Hip Fracture in a Male Patient with Multiple Sclerosis and Current Recommendations
by: Sibel Başaran, et al.
Published: (2015-12-01)

New possibilities for the treatment of glucocorticoid-induced osteoporosis
by: I.A. Baranova
Published: (2014-05-01)

Baseline characteristics of postmenopausal women with osteoporosis treated with teriparatide in a real-world setting in Latin America: a subregional analysis from the Asia and Latin America Fracture Observational Study (ALAFOS)
by: Joao L. Cunha-Borges, et al.
Published: (2019-11-01)

Effect of Teriparatide on Subsequent Vertebral Fractures after Instrumented Fusion Surgery for Osteoporotic Vertebral Fractures with Neurological Deficits
by: Keishi Maruo, et al.
Published: (2019-04-01)

Surgical outcome of atypical subtrochanteric and femoral fracture related to bisphosphonates use in osteoporotic patients with or without teriparatide treatment
by: Wen-Ling Yeh, et al.
Published: (2017-12-01)

Teriparatide in East Asian Postmenopausal Women with Osteoporosis in a Real-World Setting: A Baseline Analysis of the Asia and Latin America Fracture Observational Study (ALAFOS)
by: Chen CH, et al.
Published: (2020-01-01)

Cost‐Effectiveness of Sequential Teriparatide/Alendronate Versus Alendronate‐Alone Strategies in High‐Risk Osteoporotic Women in the US: Analyzing the Impact of Generic/Biosimilar Teriparatide
by: Takahiro Mori, et al.
Published: (2019-11-01)

Current treatment of osteoporosis
by: Subramanian Nallasivan
Published: (2019-01-01)

Teriparatide in East Asian Postmenopausal Women with Osteoporosis in a Real-World Setting: A Baseline Analysis of the Asia and Latin America Fracture Observational Study (ALAFOS) [Corrigendum]
by: Chen CH, et al.
Published: (2020-03-01)

Extremely elevated serum alkaline phosphatase level upon treatment with teriparatide: a case report
by: Ali Javinani, et al.
Published: (2020-07-01)

Post Pregnancy Severe Spinal Osteoporosis with Multiple Vertebral Fractures and Kyphoscoliosis in a Multigravida: A Rare Case with Management
by: Shailesh Hadgaonkar, et al.
Published: (2015-08-01)

Prevention of vertebral fractures in primary osteoporosis with once-weekly teriparatide: A systematic review and meta-analysis of randomized controlled trials
by: Rimesh Pal, et al.
Published: (2021-01-01)

Effects of Weekly Teriparatide Administration for Vertebral Stability and Bony Union in Patients with Acute Osteoporotic Vertebral Fractures
by: Kazuma Kitaguchi, et al.
Published: (2019-10-01)

The fast degradation of β-TCP ceramics facilitates healing of bone defects by the combination of BMP-2 and Teriparatide
by: Zhongjie Xie, et al.
Published: (2019-04-01)

Severe idiopathic osteoporosis in a premenopausal woman: A case for dual therapy
by: Sudarsanababu Lalitha Soumya, et al.
Published: (2020-01-01)

Efficacy of once-weekly and twice-weekly injections of teriparatide by patient characteristics: A post hoc analysis of the TWICE study
by: Toshitsugu Sugimoto, et al.
Published: (2021-03-01)

Cannot write session to /tmp/vufind_sessions/sess_92opsd8o43kcp3j082c6vnv80r